Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3
阿昔替尼 (AG-013736) 的非临床抗血管生成和抗肿瘤活性,阿昔替尼是一种口服、强效、选择性的血管内皮生长因子受体酪氨酸激酶 1、2、3 抑制剂
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-08-0652
Dana D Hu-Lowe, Helen Y Zou, Maren L Grazzini, Max E Hallin, Grant R Wickman, Karin Amundson, Jeffrey H Chen, David A Rewolinski, Shinji Yamazaki, Ellen Y Wu, Michele A McTigue, Brion W Murray, Robert S Kania, Patrick O'Connor, David R Shalinsky, Steve L Bender